Jun 9, 2010 · 5:30 PM
This location is shown only to members
I think everyone in the biotechnology field is aware of the promise of personalized medicine, and aware of how genomics and transcriptomics projects are producing large volumes of interesting research data. But the path to turning those discoveries into diagnostic and therapeutic products is not straightforward. All of us probably have different takes on this, as bioinformaticians, statisticians, bench scientists, disease researchers, physicians, and of course, as patients. Having an informal discussion of these views could be very educational and productive.